Alacrita developed techno-commercial development plans for selected top priority projects. The client, King's Commercialisation Institute, convened an expert panel which then selected projects which would benefit most from focussed financial support for work to reach one or more value-creating milestones and thereby progress toward partnering and/or spin-out goals.
This assignment was conducted over several months and was composed of three phases:
- IP audit: Using a project characterization template running on a secure web-based platform, we surveyed several hundred principal investigators (PIs) to identify potentially commercializable projects with filed or patentable IP. This encompassed the entire life science research portfolio of the university including therapeutics, biomarkers/diagnostics and medical devices.
- Project prioritization: Our consulting team, comprised of pharma, biotech, diagnostics and medtech industry specialists, analyzed the information received from the PIs and validated it through a combination of internal analysis, external research and telephone interviews.
In order to enable projects to be ranked into priority categories for the next stage of the analysis they were scored according to their:
- value in use
- market attractiveness
- Techno-commercial development plans: We developed development plans for selected top-priority projects. Our client convened an expert panel which selected projects most suited for focused financial support in order to reach one or more value-creating milestones and thereby progress toward partnering and/or spin-out goals.